ClariVest Asset Management’s West Pharmaceutical WST Stock Holding History

ClariVest Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.65K	Hold	5	–	–	﹤0.01%	546
2024 Q2	$1.65K	Sell	5 -3	-38%	-$1.06K	﹤0.01%	546
2024 Q1	$3.16K	Buy	8 +3	+60%	+$1.11K	﹤0.01%	520
2023 Q4	$1.77K	Hold	5	–	–	﹤0.01%	569
2023 Q3	$2K	Buy	5 +2	+67%	+$773	﹤0.01%	541
2023 Q2	$1K	Hold	3	–	–	﹤0.01%	644
2023 Q1	$1K	Hold	3	–	–	﹤0.01%	706
2022 Q4	$1K	Hold	3	–	–	﹤0.01%	676
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	661
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	673
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	677
2021 Q4	$1K	Hold	3	–	–	﹤0.01%	734
2021 Q3	$1K	Hold	3	–	–	﹤0.01%	737
2021 Q2	$1K	Hold	3	–	–	﹤0.01%	723
2021 Q1	$1K	Hold	3	–	–	﹤0.01%	715
2020 Q4	$1K	Hold	3	–	–	﹤0.01%	737
2020 Q3	$1K	Buy	+3	New	+$794	﹤0.01%	727
2020 Q2	–	Sell	-30,500	Closed	-$4.64M	–	858
2020 Q1	$4.64M	Buy	30,500 +1,800	+6%	+$277K	0.14%	107
2019 Q4	$4.31M	Sell	28,700 -900	-3%	-$131K	0.1%	158
2019 Q3	$4.2M	Buy	+29,600	New	+$4.08M	0.09%	183
2014 Q1	–	Sell	-44,310	Closed	-$2.17M	–	673
2013 Q4	$2.17M	Sell	44,310 -500	-1%	-$23.4K	0.09%	154
2013 Q3	$1.84M	Sell	44,810 -31,224	-41%	-$1.19M	0.08%	169
2013 Q2	$2.67M	Buy	+76,034	New	+$2.5M	0.12%	158

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClariVest Asset Management's WST Position: Q3 2024 in Review

ClariVest Asset Management held its West Pharmaceutical (WST) position steady in Q3 2024 at 5 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

ClariVest Asset Management first reported a position in WST in Q2 2013 and has held it in 23 quarters since. The position peaked at $4.64M in Q1 2020. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

ClariVest Asset Management held 5 shares of West Pharmaceutical worth $1.65K as of Q3 2024.
ClariVest Asset Management left its West Pharmaceutical share count unchanged in Q3 2024.
West Pharmaceutical made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #546 holding.
ClariVest Asset Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 23 quarters since.
ClariVest Asset Management's West Pharmaceutical position peaked at $4.64M in Q1 2020.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.